Mark Wappett
Impact in
-
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- CAR-T cell therapy research
Papers in
-
- Ubiquitin and proteasome pathways 3
- Gene expression and cancer classification 2
- RNA modifications and cancer 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Co-authors
- Elizabeth A. Harrington (2 shared papers)Margaret H. Veldman-Jones (2 shared papers)Chris Harbron (2 shared papers)Gayle Marshall (1 shared paper)Alan Sharpe (1 shared paper)Claire Rooney (1 shared paper)Roz Brant (1 shared paper)Catherine Geh (1 shared paper)
- Journals
- Cancer Research (5 papers)Scientific Reports (2 papers)Cell Death Discovery (1 paper)Clinical and Translational Medicine (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Mark Wappett
18 papers receiving 494 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 127
- Oncology 123
- Pathology and Forensic Medicine 56
- Molecular Biology 233
- Genetics 32
Countries citing papers authored by Mark Wappett
This map shows the geographic impact of Mark Wappett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wappett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wappett more than expected).
Fields of papers citing papers by Mark Wappett
This network shows the impact of papers produced by Mark Wappett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wappett. The network helps show where Mark Wappett may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Wappett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 249 | |
| 2 | 2014 | 55 | |
| 3 | 2016 | 32 | |
| 4 | 2016 | 28 | |
| 5 | 2020 | 25 | |
| 6 | 2013 | 23 | |
| 7 | 2012 | 21 | |
| 8 | 2016 | 15 | |
| 9 | 2015 | 15 | |
| 10 | 2024 | 10 | |
| 11 | 2022 | 10 | |
| 12 | 2021 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2022 | 4 | |
| 15 | 2019 | 3 | |
| 16 | 2020 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 1 |
About Mark Wappett
Mark Wappett is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Organic Chemistry, Oncology and Cancer Research, having authored 18 papers that have together received 503 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Gene expression and cancer classification (2 papers), Cancer Genomics and Diagnostics (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Lymphoma Diagnosis and Treatment (2 papers), RNA modifications and cancer (2 papers), Synthesis and Biological Evaluation (2 papers) and Cancer-related molecular mechanisms research (1 paper). The work is most often cited by research in Cancer Research (127 citations), Oncology (123 citations), Pathology and Forensic Medicine (56 citations), Molecular Biology (233 citations) and Genetics (32 citations). Mark Wappett has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Elizabeth A. Harrington, Margaret H. Veldman-Jones, Chris Harbron, Gayle Marshall, Alan Sharpe, Claire Rooney, Roz Brant, Catherine Geh, Hollie Emery and J. Carl Barrett. Their work appears in journals such as Cancer Research, Scientific Reports, Cell Death Discovery, Clinical and Translational Medicine and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.